Korean J Otorhinolaryngol-Head Neck Surg.  2020 Dec;63(12):615-619. 10.3342/kjorl-hns.2020.00787.

Hurthle Cell Carcinoma of the Thyroid: A Case Report of 12 Cases

• Kim JJ
• Kang JY
• Choi IJ
• Lee MC

• KMID: 2511311
• DOI: http://doi.org/10.3342/kjorl-hns.2020.00787

Abstract

Hurthle cell carcinoma (HCC) is a relatively rare disease, which comprises about 3% of differentiated thyroid carcinoma. HCC is considered to have more aggressive clinical behavior compared with other differentiated thyroid carcinoma. However, there has been no consensus about clinical behavior and optimal treatment of HCC because of insufficient reports. Moreover, owing to geographical characteristics, HCC is rarer in Korea than in western countries. Based on 2017 World Health Organization classification, HCC is newly classified as an individual group, not as a subtype of follicular thyroid carcinoma. Therefore, we report data of 12 HCC patients who underwent surgery in our center from January 2000 to May 2020 with a review of the literature.

Keyword

Hurthle cell; Prognosis; Thyroid carcinoma; Thyroidectomy